000 01203 a2200337 4500
005 20250514214939.0
264 0 _c20050318
008 200503s 0 0 eng d
022 _a0885-0615
040 _aNLM
_beng
_cNLM
100 1 _aMaloney, Dennis M
245 0 0 _aInstitutional review boards (IRBs) and risk considerations for children.
_h[electronic resource]
260 _bHuman research report
_cSep 2004
300 _a1-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAttention Deficit Disorder with Hyperactivity
_xdrug therapy
650 0 4 _aChild
650 0 4 _aDextroamphetamine
_xadverse effects
650 0 4 _aEthical Review
650 0 4 _aEthics Committees, Research
650 0 4 _aGovernment Regulation
650 0 4 _aHuman Experimentation
_xlegislation & jurisprudence
650 0 4 _aHumans
650 0 4 _aNational Institute of Mental Health (U.S.)
650 0 4 _aNontherapeutic Human Experimentation
_xlegislation & jurisprudence
650 0 4 _aRisk Assessment
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
773 0 _tHuman research report
_gvol. 19
_gno. 9
_gp. 1-3
999 _c15352983
_d15352983